Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094701 · ClinicalTrials.gov registry record · NA
Hip Arthroscopy Postoperative Opioid Demands
A NA study of Pain and Opioid Use, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT04094701: Recruiting NA study of Pain and Opioid Use, sponsored by Rush University Medical Center.
NCT04094701 is a NA study of Pain and Opioid Use that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 170 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04094701, a NA study of Pain and Opioid Use, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.
Primary Outcome
Visual Analog Scale: unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
Conditions Studied
Interventions
- OTHER Control Group Regimen
- OTHER Opioid reduced regimen
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT04094701 shows while recruiting
NCT04094701 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (44% lower).
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Control Group Regimen is the first listed.
NCT04094701 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04094701 about?
NCT04094701 is a clinical study titled "Hip Arthroscopy Postoperative Opioid Demands". This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatmen...
What is the current status of trial NCT04094701?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2020-10-21. Estimated completion is 2027-03.
What conditions does trial NCT04094701 study?
This clinical trial studies the following conditions: Pain, Opioid Use, Femoral Acetabular Impingement, Labral Tear, Glenoid.
What interventions are being tested in trial NCT04094701?
The interventions under investigation include: Control Group Regimen (OTHER), Opioid reduced regimen (OTHER).
Who is sponsoring clinical trial NCT04094701?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04094701 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04094701's enrollment target sits among peer trials
170 106th of 374 higher than 269 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
- NCT04614103 · 170 participants · Phase 2
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI